Tappet

← Back to Tappet
Philadelphia feed of tappet.org
Health Care · Nov 20, 2026

American Association for Cancer Research - From Promise to Proof: Personalized Melanoma mRNA Vaccine Delivers Phase III Success

Results from a phase III trial showed that a cancer vaccine can improve outcomes for certain patients with melanoma, highlighting the potential of personalized vaccines to reshape cancer treatment. The post From Promise to Proof: Personalized Melanoma mRNA Vaccine Delivers Phase III Success appeared first on American Association for Cancer Research (AACR) .

https://www.aacr.org/blog/2026/10/26/from-promise-to-proof-personalized-melanoma-mrna-vaccine-delivers-phase-iii-success/

Join the conversation on Tappet